Billiontoone (NASDAQ:BLLN) Trading Up 7.7% – Should You Buy?

Billiontoone, Inc. (NASDAQ:BLLN) was up 7.7% on Monday . The stock traded as high as $88.35 and last traded at $88.9690. Approximately 299,183 shares changed hands during trading, a decline of 22% from the average daily volume of 383,568 shares. The stock had previously closed at $82.63.

Wall Street Analyst Weigh In

Several analysts have recently commented on the company. Guggenheim raised their target price on Billiontoone from $100.00 to $120.00 and gave the company a “buy” rating in a research note on Wednesday, May 13th. BTIG Research cut their price target on Billiontoone from $140.00 to $130.00 and set a “buy” rating on the stock in a report on Thursday, May 7th. JPMorgan Chase & Co. raised their price objective on Billiontoone from $120.00 to $125.00 and gave the company an “overweight” rating in a research note on Thursday, May 7th. Wells Fargo & Company decreased their price objective on Billiontoone from $110.00 to $90.00 and set an “equal weight” rating for the company in a report on Thursday, March 5th. Finally, Weiss Ratings upgraded Billiontoone from a “sell (d)” rating to a “sell (d+)” rating in a report on Friday. Six equities research analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $125.29.

Billiontoone Stock Up 4.6%

The company has a debt-to-equity ratio of 0.18, a current ratio of 10.92 and a quick ratio of 10.58. The firm has a market capitalization of $3.97 billion and a P/E ratio of 157.09. The company has a 50-day moving average price of $79.84.

Billiontoone (NASDAQ:BLLN) last released its quarterly earnings results on Wednesday, May 6th. The company reported $0.34 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.01 by $0.33. The company had revenue of $108.39 million for the quarter, compared to analyst estimates of $95.81 million. Billiontoone’s revenue for the quarter was up 83.8% on a year-over-year basis. During the same quarter last year, the firm posted ($0.39) EPS. As a group, equities research analysts expect that Billiontoone, Inc. will post 0.93 EPS for the current year.

Institutional Investors Weigh In On Billiontoone

Several institutional investors have recently bought and sold shares of BLLN. Rossby Financial LCC purchased a new stake in Billiontoone in the 4th quarter valued at $25,000. Wells Fargo & Company MN purchased a new position in Billiontoone during the 4th quarter worth $76,000. Smartleaf Asset Management LLC purchased a new position in Billiontoone during the 4th quarter worth $80,000. Nano Cap New Millennium Growth Fund L P bought a new stake in shares of Billiontoone in the 4th quarter worth $82,000. Finally, Renaissance Capital LLC purchased a new stake in shares of Billiontoone in the fourth quarter valued at about $201,000.

About Billiontoone

BillionToOne (NASDAQ: BLLN) is a molecular diagnostics company that develops and commercializes high-precision genetic testing solutions based on single-molecule counting technology. The company’s platform is designed to detect and quantify rare genetic variants and chromosomal abnormalities from cell-free DNA, with a primary focus on applications in prenatal screening and other clinical genetic tests where sensitivity and specificity at very low allele fractions are critical.

BillionToOne’s offerings center on assay development and clinical testing workflows that enable non-invasive prenatal testing (NIPT) and targeted molecular diagnostics.